Improvement of leukemia-free survival (ITS) and reduction of relapse incidence by allogeneic stem cell transplantation (SCT) in elderly patients (pts) with AML, irrespective of the FLT3-ITD and npm status except npm+/flt3(ITD)-

被引：0
|
作者：
Niederwieser, O.
Schueler, F.
Hegenbart, U.
Maschmeyer, G.
Fischer, T.
Junghanss, C.
Wolf, H.
Sayer, H. G.
Kreibich, U.
Doelken, G.
机构：
[1] Univ Leipzig, Dept Hematol Oncol & Hemostasis, D-04109 Leipzig, Germany
[2] Univ Hosp, Leipzig, Germany
[3] Amyloidosis Ctr, Heidelberg, Germany
[4] Potsdam Klinikum, Potsdam, Germany
[5] Univ Magdeburg, D-39106 Magdeburg, Germany
[6] Univ Rostock, D-18055 Rostock, Germany
[7] Univ Halle Wittenberg, D-06108 Halle, Germany
[8] Jena Uniklinikum, Jena, Germany
[9] Braun Krankenhaus, Zwickau, Germany
[10] Ernst Moritz Arndt Univ Greifswald, Greifswald, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6505
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Improved survival in AML patients with a high FLT3-ITD mutation rate after allogeneic transplantation
    Ehninger, G.
    Bornhaeuser, M.
    Kramer, M.
    Roellig, C.
    Wandt, H.
    Haenel, M.
    Einsele, H.
    Aulitzky, W.
    Schmidt, N.
    Berdel, W.
    Stelljes, M.
    Baldus, C.
    Mackensen, A.
    Platzbecker, U.
    Schaich, M.
    Thiede, C.
    Ho, A.
    Schetelig, J.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S3 - S3
  • [22] FLT3-ITD Allelic Ratio and NPM1 Mutation Do Not Impact Outcomes in Acute Myeloid Leukemia Patients with FLT3-ITD after Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Propensity Score- Matching Study
    Zhou, Cuiyan
    Zheng, Fengmei
    Xu, Lanping
    Zhang, Xiaohui
    Chang, Yingjun
    Mo, Xiaodong
    Sun, Yuqian
    Huang, Xiaojun
    Wang, Yu
    TRANSPLANTATION AND CELLULAR THERAPY, 2023, 29 (07): : 456.e1 - 456.e11
  • [23] Detection of relapse following allogeneic stem cell transplantation in AML:: NPM1-mutations precede the FLT3-LM/ITD and changes in chimerism
    Bacher, U.
    Badbaran, A.
    Fehse, B.
    Zabelina, T.
    Zander, A. R.
    Kroeger, N.
    ANNALS OF HEMATOLOGY, 2008, 87 : S4 - S4
  • [24] FLT3 AND NPM1 GENE MUTATIONS IN PATIENTS WITH ACUTE MYELOID LEUKEMIAS AND THE IMPACT OF FLT3-ITD MUTATIONS ON THE SURVIVAL OF PATIENTS WITH A NORMAL KARYOTYPE
    Martynkevich, I. S.
    Gritsayev, S. V.
    Moskalenko, M. V.
    Ivanova, M. P.
    Aksenova, V. Yu
    Tiranova, S. A.
    Abdulkadyrov, K. M.
    TERAPEVTICHESKII ARKHIV, 2010, 82 (12) : 33 - 39
  • [25] Role of autologous hematopoietic stem cell transplantation according to the NPM1/FLT3-ITD molecular status for cytogenetically normal AML patients: A GOELAMS study
    Guieze, Romain
    Cornillet-Lefebvre, Pascale
    Lioure, Bruno
    Blanchet, Odile
    Pigneux, Arnaud
    Recher, Christian
    Bonmati, Caroline
    Fegueux, Nathalie
    Bulabois, Claude-Eric
    Bouscary, Didier
    Vey, Norbert
    Delain, Martine
    Turlure, Pascal
    Himberlin, Chantal
    Harousseau, Jean-Luc
    Dreyfus, Francois
    Bene, Marie C.
    Ifrah, Norbert
    Chevallier, Patrice
    AMERICAN JOURNAL OF HEMATOLOGY, 2012, 87 (12) : 1052 - 1056
  • [26] FLT3-ITD Mutation and Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia: A Case Study
    Saeed, Shahzeb
    Nagaraj, Raghu Halappa
    Grezenko, Han
    Rehman, Abdur
    Shehryar, Abdullah
    Anwaar, Mohammad Ahsan
    Lazarevic, Slobodan
    Shahzed, S. M. Iram
    Das, Archana
    Vargas, Karla I.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (07)
  • [27] Study of HOTAIR LncRNA expression in Egyptian AML patients in context to FLT3-ITD and NPM1 mutations status
    Fouad, Neveen B.
    Salah, Mona
    AMERICAN JOURNAL OF HEMATOLOGY, 2019, 94 : S28 - S28
  • [28] Prolonged Remission of FLT3-ITD Positive AML Treated With Sorafenib Post Allogeneic Stem Cell Transplantation
    Moukadem, Hiba
    Antar, Ahmad
    Kharfan-Dabaja, Mohamed
    Bazarbachi, Ali
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2014, 14 : S126 - S127
  • [29] The effect of FLT3-ITD and NPM1 mutation on survival in intensively treated elderly patients with cytogenetically normal acute myeloid leukemia
    Rashidi, Armin
    Wolach, Ofir
    El-Jawahri, Areej
    Ho, Vincent T.
    DiPersio, John F.
    Soiffer, Robert
    Stone, Richard M.
    Chen, Yi-Bin
    LEUKEMIA & LYMPHOMA, 2016, 57 (08) : 1977 - 1979
  • [30] The value of allogeneic stem cell transplantation in patients with intermediate risk (ELN) acute myeloid leukemia with no FLT3-ITD, no NPM1 mutations and no CEBPA double mutations
    Heidrich, K.
    Thiede, C.
    Schaefer-Eckart, K.
    Schmitz, N.
    Aulitzky, W. E.
    Kraemer, A.
    Roesler, W.
    Haenel, M.
    Einsele, H.
    Baldus, C. D.
    Trappe, R. U.
    Stoelzel, F.
    Middeke, J. M.
    Roellig, C.
    Taube, F.
    Kramer, M.
    Serve, H.
    Berdel, W. E.
    Ehninger, G.
    Bornhaeuser, M.
    Schetelig, J.
    BONE MARROW TRANSPLANTATION, 2017, 52 : S81 - S81
12345